Value Delivered
Through detailed ingredient research and clinical analysis, four key ingredient combinations were identified to address the unique health challenges faced by C-section-born babies. These included GOS/FOS prebiotics, Bifidobacterium breve M-16V, Lactobacillus fermentum CECT5716, and targeted vitamins. This combination directly restored gut microbiota, reduced infection risks, and led to measurable health improvements. The formulation enabled clear product claims and positioned the company as one of the market leaders in regions with high C-section birth rates.
Problems Solved
A leading global nutrition company wanted to develop an infant formula that addressed the specific health needs of C-section-born babies. The challenge was to restore gut microbiota and reduce infection risks with a product that could meet the growing demand for clinically-backed solutions. The formula needed to resonate with parental concerns about infant health while ensuring regulatory compliance.
Solution Offered
A thorough ingredient research and competitive analysis helped identify key blends of prebiotics, probiotics, and vitamins that would support the gut microbiota of C-section-born infants. Notable ingredients included:
- GOS/FOS (prebiotics)
- Bifidobacterium breve M-16V and Lactobacillus fermentum CECT5716 (probiotics)
- Targeted vitamins to enhance immunity and gut health.
With the support of double-blind clinical trials and patent filings, the new formula proved its effectiveness, helping the client:
- Meet regulatory requirements for clear product claims
- Secure leading positions in markets with high C-section birth rates
- Communicate effectively with parents, addressing key concerns and driving consumer trust and adoption.
Download the full case study to see how clinical research and innovation helped find infant formula solutions for C-section-born babies.
Request Full Case Study
Download in PDF Format and read anytime. Fill the form to get access to this article.
